Prolight Diagnostics AB (publ) (NGM:PRLD) signed an agreement to acquire Psyros Diagnostics Ltd for SEK 65 million on January 20, 2022. Payment will be made by the issue of new shares, with 30 percent to be paid within four weeks of completion and the remaining 70 percent to be paid during the next two years, provided that predetermined milestones are achieved. All newly issued shares will have a lock-up period until December 31st, 2025.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.145 SEK | +23.93% | +23.93% | -51.83% |
17/05 | Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development | MT |
17/05 | Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-51.83% | 6.88M | |
-38.56% | 8.39B | |
+0.18% | 3.32B | |
+9.29% | 2.48B | |
-18.21% | 2.06B | |
-24.57% | 1.59B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M |
- Stock Market
- Equities
- PRLD Stock
- News Prolight Diagnostics AB
- Prolight Diagnostics AB signed an agreement to acquire Psyros Diagnostics Ltd for SEK 65 million.